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 Abstract 
As the field of drug delivery is expanding into consumer products, it is essential to advance in the 
development of efficient synthesis technologies while preserving, at the same time, human health 
and the environment for future generations. Here, the sustainable development of polymeric 
particles for drug delivery is described. Poly(ethylene glycol) methyl ether-block-poly(lactide-co-
glycolide) based particles containing dexamethasone were produced by membrane emulsification-
solvent diffusion methods. The ability of the synthesis process to control particle-size distribution 
and morphology and its green impactful (energy consumption, simple (sEF) and complete (cEF) E 
factor) were evaluated.  
Particles with sufficiently narrow distribution in their droplet size and mean diameter similar to 
the membrane pore diameter were produced by increasing the dispersed phase flux to 12.84 L h
-
1
m
-2
, minimizing the maximum shear stress to 1.12 Pa and the energy consumption to 3.96 10
5
 Jm
-
3
. The impact of the solvent used on size distribution, particles morphology and green 
performance scores was also studied. More uniform particles, with dense and slightly rough 
surface, high encapsulation efficiency and drug loading were obtained by replacing 
Dichloromethane with Ethyl acetate. The E factor was also decreased by 80%. 
Results demonstrated that membrane emulsification is an environmentally improved method for 
the production of drug delivery systems with enormous impact in terms of formulation quality, 
energy consumption reduction and waste minimization.  
 
Keywords: membrane emulsification, drug-loaded particles, energy consumption, sustainability, 
PLGA-PEG, Ethyl acetate, dexamethasone 
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 Introduction 
Among the new generation of pharmaceutical forms, polymeric particles have gained significant 
relevance due to their ability to deliver drugs at a controlled rate and toward a specific target 
1
 . 
Polymeric particles have been frequently used as drug delivery depots of drugs with low aqueous 
solubility. Approximately 40% of all new drug candidates in development, and about 70–80% in 
some therapeutic areas, are poorly absorbed orally, principally due to their low aqueous solubility. 
As the field of drug delivery is expanding into consumer products, it is essential to advance in the 
development of efficient synthesis technologies while preserving, at the same time, human health 
and the environment for future generations. The design of highly efficient particulate systems with 
high yield, minimizing solvent and energy consumption and with a reduced waste production is a 
significant challenge in particle engineering technologies. 
2–4
 Producers are making a big effort to 
create the basis to regulate process manufacturing procedures to reach high quality products, with 
high productivity and to fulfill also the requirements of the pharmacopeia 
5,6
.  
Biodegradability or biocompatibility is an essential requirement for the polymer used for 
pharmaceutical applications 
7
. Several drug delivery systems based on poly (D,L-lactide-co-
glycolide) (PLGA) family are approved by the FDA and their ability to modulate drug release are 
strictly connected with the relative amount of lactic (PLA) and glycolic acids (PGA) 
8,9
. The 
modification of PLGA with an hydrophilic and inert polymer like PEG (poly ethylene glycol) 
prolongs the circulation of the particles in the body and decreases the premature drug release 
increasing their therapeutic effect 
10
. Dexamethasone (DEX) is currently used in many biomedical 
applications such as: cell culture, ophthalmology, proliferative vitreoretinopathy, subretinal 
neovascularization, arthritis and diabetic macular edema as anti-inflammatory and 
immunosuppressant drug 
11
. The main limitations of this drug for pharmaceutical applications are 
its high hydrophobicity and high doses necessary to reach its therapeutic level 
11,12
. Consequently, 
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 various delivery systems have been developed and the majority of them are based on its 
encapsulation within both natural and synthetic polymers 
11,13–15
.  
Microencapsulation by solvent evaporation is a widely applied technique for entrapping insoluble 
or poorly water-soluble drugs. Different aspects have to be taken into account to choose the most 
appropriate solvent for the preparation of polymeric particles by this technique: 1) the ability to 
dissolve the polymer 2) a reduced solubility in the continuous phase 3) high volatility 4) low 
toxicity 
7
. Solvents used during polymer particle synthesis are often volatile organic compounds 
and their use is associated to some concerns about their potential environmental impact (some of 
them are able to form low-level ozone and smog through free radical air oxidation processes), 
their adverse health effects (ranging from carcinogenic properties to headaches and allergic skin 
reactions, eye irritations) and their hazardous properties (they are often highly flammable)
16
. 
Dichloromethane (DMC) is one of the most used solvents for the production of polymeric particles 
via emulsification and subsequent solvent-evaporation due to its high volatility, low boiling point 
and high immiscibility with water 
7
. Ethyl acetate (EA) has been proven to be a potential substitute 
of DCM with less toxicity 
7,17–20
. It has been classified as “recommended” considering the safety, 
health and environmental scores while DCM is considered “problematic” or “hazardous” 
21,22
.  
Microengineered technologies are emerging as promising particle fabrication methods for their 
ability to generate droplets individually by injecting the dispersed phase in the continuous phase 
through a single (i.e., microfluidic device) or a multitude of channel/pores (i.e., membranes) 
23,24
. 
These techniques allow the production of uniformly sized droplets with tuned sizes and improved 
encapsulation efficiency 
25–28
. Polymeric particles can be obtained by combining membrane 
emulsification with additional physical (i.e., evaporation/solvent diffusion) or chemical (cross-
linking, coacervation and interfacial polymerization) treatments. This allows controlling the 
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 physicochemical properties, size, size distribution and drug loading in the resulting particles. 
Membrane systems have been indicated as new “green process engineering” able to redesign 
traditional operations 
29
 however; to the best of our knowledge, the greenness of membrane 
emulsification has never been measured. 
In the present work, PLGA-PEG microparticles were produced by membrane emulsification/solvent 
diffusion. The effect of the different solvents used for polymer dissolution (EA or DCM), fluid-
dynamics and operating conditions applied during membrane emulsification and solidification 
steps, respectively, were investigated. In particular, the sustainability assessment of the process 
was evaluated by considering the properties of the polymeric particles produced (size, size 
uniformity, and drug encapsulation efficiency) together with the energy consumption. To 
determine the green impact of the particle production method proposed, the metric based on the 
Green Aspiration Level™ (GAL) was used 
4,30
 Many authors dedicated their efforts to optimize 
membrane emulsification processes for manufacturing structured microparticles with tailored 
properties 
31
 however; to the best of our knowledge, this work is the first one in which the 
greenness of the process was measured. A comparison with previous research carried out for the 
production of DEX-loaded PLGA particles is also reported to emphasize the advances of the 
present work.  
 
Materials and Method 
Materials 
The polymer used in this study was Resomer RGP d 5055 (Di-block PLGA (50:50) PEG (5kDa, 5%) 
(PLGA-PEG), EVONIK, Germany). Dexamethasone (DEX) supplied by SIGMA–Aldrich was used as 
model drug. Pluronic F127 was used as stabilizer in the external phase during the 
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 microencapsulation process and Ethyl acetate (EA) and Dichloromethane (DCM) were used as non-
polar solvents. Surfactants and solvents (analytical grade) were purchased from SIGMA–Aldrich. 
 
Dispersed Phase and continuous phase preparation   
The dispersed phase used to produce the o/w emulsion was obtained by dissolving PLGA-PEG in 
EA at a polymer concentration of 10 mg mL
-1
. The continuous phase was a water solution 
containing Pluronic F127 at 11.6 mg mL
-1
. A continuous phase saturated in Ethyl Acetate was used 
during the emulsification step in order to avoid its diffusion from the formed droplets while a non-
saturated continuous phase was used as dilution medium for the preparation of the particles by 
solvent diffusion, after emulsification. 
To evaluate the dexamethasone encapsulation efficiency and drug loading, the dispersed phase 
was modified by including dexamethasone (1 mg mL
-1
). 
 
Membrane emulsification step 
The o/w emulsion was prepared by using a Shirasu porous glass-based (SPG, Miyazaki, Japan), 
hydrophilic tubular membrane with a pore size of 1 µm having a membrane area of 31.30 cm
2
. A 
schematic representation of the membrane and the membrane emulsification plant are reported 
in Figure 1. The dispersed phase was injected through the membrane under gas pressure using a 
transmembrane pressure (PTM) between 0.18 and 0.45 Pa, corresponding to a dispersed flux (Jd) 
between 1.16 and 30.67 Lh
-1
m
-2
. The dispersed phase flux (Jd) was determined as follows:  
 
Equation 1: J =   
Where, Qd is the Dispersed Phase Flow (L·h
-1
) and A is the Membrane Area (m
2
). It represents a 
measurement of membrane emulsification throughput. 
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Figure 1. A) Schematic representation of the membrane emulsification set up. B) Schematic 
representation of membrane emulsification process. C) Schematic representation of solvent 
diffusion - evaporation process.  
 
The continuous phase was agitated by means of a pulsed back-and-forward mode along the lumen 
side of the membrane by using a programmable peristaltic pump (Digi-Staltic double-Y 
Masterflex® pump Micropump, model GJ-N23.JF1SAB1). 
32,33
 The maximum shear stress (τmax) [Pa] 
at the membrane surface depends on the frequency (f) [Hz] and on the amplitude (α) [m] of the 
continuous phase flow. The amplitude and the frequency of the oscillation were calculated 
considering the flow rate of the pump (Qc) [m
3
·s
-1
] and the volume of the continuous phase that 
was pumped inside the membrane before the flow direction was reversed (Vc) [L]. These 
parameters were calculated as follows:  
 
Equation 2: 	
 = 2.. 
Equation 3:  =  
Equation 4:  =   
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 Where μc is the Continuous phase viscosity [Pa·s] and ρc is the Continuous phase density [kg·m
-3
]. 
The effect of amplitude was fixed at 4.7·10
-2
m and frequency was modified between 1.48 and 3.57 
Hz.  
The volume ratio % of the dispersed phase obtained for each experiment respect to the 
continuous phase volume (DP/CP) was 20 %. The emulsification process was carried out at 20 ± 5
º
C. 
The membrane was pre-wetted in the continuous phase solution before each experiment. After 
each experiment, a membrane cleaning step was carried out by using acetone and EA 
34
.  
The water permeability of a brand new membrane before each experiment was measured to 
evaluate its recovery after the cleaning procedure and it was set at 7523.00 ± 80.00 Lh
-1
m
-2
bar
-1
. 
 
Solidification Step 
The liquid droplets were precipitated as solid microparticles by the addition of a certain volume of 
non-saturated continuous phase (diffusion volume, Vd). The diffusion volume was selected taking 
into account the theoretical minimum volume (Vth) (i.e., the minimum theoretical amount of 
diffusion volume necessary to ensure the complete diffusion of solvent), calculated using equation 
1. The Vd/Vth ratio was changed from 0 to 3 in order to control the solidification rate of the 
droplets. Vd/Vth = 0 corresponded to the case in which the solidification was carried out without 
the addition of the non-saturated continuous phase.  
 
Equation 5:    !" = #$%	'()*+,-.∗0$'()*+,-.  
Where Vth (mL) is the theoretical minimum volume of the organic solvent, VDP (mL) is the dispersed 
phase volume, Ssolvent (mL solvent/mL water) is the solubility of the organic solvent in water and VCP 
(mL) is the continuous phase volume. 
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 The organic solvent was removed by evaporation in a fume hood under stirring for 3 hours. The 
resulting particles were centrifuged at 2100 g for 10 min and the supernatant was stored for 
further analysis while the pellet was lyophilized using a LyoAlfa 10/15 from Telstar for 24h (0.01 
bar, -40
o
C).  
 
Particles characterization 
Particle analysis  
The particle size analysis of the resulting microparticles was performed by using laser diffraction in 
a Malvern Mastersizer 2000 (Malvern Instruments, Worcestershire, UK). The software used to 
collect and analyze the data was a Malvern 2000 Software 5.61 using a refractive index of 1.55 
PLGA-PEG polymer. 
Microparticles were also observed by Scanning Electron Microscopy (SEM) using an Inspect F50 
SEM operated at 10–15 kV; FEI from Eindhoven, Netherlands at the LMA-INA-Universidad de 
Zaragoza facilities. To perform the measurement, the sample was stained with a phosphotungstic 
acid solution (75 mg mL
-1
) and washed three times with distilled water. One drop of the particulate 
dispersion was placed on a glass slide, dried overnight and cover with platinum before observation.  
The size distribution was expressed in terms of the surface weighed median diameter or Sauter 
diameter (D(3,2)) calculated according to Equation 2. Volume weighed median diameter or 
Brouckere diameter (D(4,3)) was calculated according Equation 3.  
 
Equation 6: 13,2 = ∑56
786
∑5686
     
Equation 7: 14,3 = ∑56
:86
∑56786
    
Where Di is particle diameter of class i and ni is number of particles in class i. 
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 The width of particle size distribution was expressed as Span number calculated by Equation 4 
Equation 8: ;<=> = ?@A?? 	
Where D(X) is the diameter corresponding to the percent of volume on a relative cumulative 
particle size curve. 
 
Encapsulation Efficiency and Drug Loading 
The encapsulation efficiency (EE) and drug loading (DL) were evaluated according to the following 
equations (Equation 5 and Equation 6):  
 
Equation 9: EE	 = ?CD	EFGHI?CD	JKJHL 	 ∗ 100 
Equation 10: DL = ?CD	EFGHIQRS	JKJHL 	 ∗ 100 
Where EE is the encapsulation efficiency (%), DEXencap stands for Dexamethasone mass 
encapsulated (mg) measured by mass balance, DEXtotal stands for the initial Dexamethasone mass 
in the dispersed phase (mg), DL represents the drug loading efficiency (%) and PLGAtotal stands for 
the initial PLGA mass in the dispersed phase (mg). The particles were separated from the liquid by 
centrifugation at 2100 g. DEX content in the supernatant was determined by HPLC. A reversed-
phase C18 column (2.6 µm, 50x4.6mm Phenomenex kinetex) was used. The mobile phase was 
acetonitrile/water at a pH 3 (50/50 v/v). The flow rate was 0.4 mL min
-1
 and the detection was 
obtained at 260 nm with a UV detector. The linear regression coefficient (R2) was determined in 
the range 0.01–30 μg/mL as 0.9993 (n=10).  
 
Green analysis and energy consumption  
Energy consumption calculation 
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 The energy consumption was evaluated considering the production with a DP/CP of 20%. The 
energy required was calculated in terms of energy density (Ev, J m
-3
), according to the following 
equation 
35
: 
Equation 11: Ev = UV  
where P stands for the effective power input (J s-1) and QE stands for the volume flow rate of the 
emulsion (m
3
s
-1
). Power input was calculated as follows: 
 
Equation 12: W = X∆U0$∗0$Z0$ [ 
Where ∆PCP is the pressure drop along the membrane module, QCP is the flow rate of the pump 
used to generate the pulsed flow and ηCP is the pump efficiency. 
 
Green factor calculation  
E factor is a simple analysis used to calculate the greenness of a process. Process waste was 
determined via complete E factor calculation based on a simple mass-balance 
4
. Two factors were 
determined: simple E factor (sEF) and complete E factor (cEF) (in which solvent and water 
consumed during the process are also included) using equation 13 and equation 14, respectively, 
adapted to the specific case of particle production: 
 
Equation 
13:	sEF	 = ∑^_H`	aHJEbcHLd%∑^_EHeEFJdA^QbKfGJ^QbKfGJ =
	^QKLg^Eb%^?bfe%^dfbhHGJHFJA^IHbJcGLEd^IHbJcGLEd   
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 Equation 14: 
∑^_H`	aHJEbcHLd%∑^_EHeEFJd%∑^'KLiEFJd%∑jHJEbA^QbKfGJ
^QbKfGJ =
^QKLg^Eb%^?bfe%^dfbhHGJHFJ%^dKLiEFJ%^`HJEbA^IHbJcGLEd
^IHbJcGLEd  
Where Σm(Raw Materials) represents the total mass of polymer and drug used for producing a 
batch of product. Σm(Reagent) represents the total mass of the reagents used in the process, 
principally the surfactant. m(Product), Σm(solvent) and Σm(water) represent the masses of 
particles produced, mass of solvent and mass of water, respectively. cEF is used in GAL-based 
analysis enabling organizations to calculate their green performance scores. 
The process mass intensity (PMI), calculated as the ratio of the total mass of materials to the mass 
of the product, has been selected from ACS Green Chemistry Institute Pharmaceutical Roundtable 
as indicator of sustainability for the pharmaceutical sector:  
Equation 15: PMI = ∑^	aHJEbcHLd		cFIfJ^QbKfGJ = 	cEF + 1 
Where the Σm(Materials input) includes the total mass of polymer, drug, reagents used in the 
process (i.e., surfactant), mass of solvent and mass of water. The cEF and PMI can be used 
interchangeably in the GAL methodology
36
 and in this article, we will refer to it as cEF.  
Percent’s relation (%cEF and % solvent+water) was calculated using equation 16 and 17: 
 
Equation 16:   %qrs =	 tuvuv ∗ 100% 
Equation 17:  %wxyz{>| + }=|{~ = t8!%	!!!	  
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 Results and Discussion  
Effect of fluid-dynamic conditions during membrane emulsification process 
The fluid-dynamic conditions play an important role during particle manufacturing by membrane 
emulsification, determining the droplet size and droplet size distribution of the emulsion before 
the solidification step. The influence of the dispersed phase flux and shear stress on PLGA-PEG 
particle sizes and size distributions have been studied in order to identify the operation conditions 
that provide the smaller droplets with the highest uniformity and productivity. On the other hand, 
the dispersed phase flux and shear stress are strictly correlated with the throughput and energy 
consumption, respectively. These two parameters have also been evaluated in order to 
demonstrate the sustainability of the productive process.  
 
Effect of dispersed phase flux  
The effect of dispersed phase flux on PLGA-PEG particle size and particle size distribution has also 
been investigated. Figure 2A describes the resulting particle sizes for D[4,3], D[3,2] and span of 
PLGA-PEG microparticles produced by pulsed back-and-forward ME as a function of the dispersed 
phase flux in the range from 1.15 to 30.67 Lh
-1
m
-2
, keeping constant the maximum shear stress 
(2.48 Pa).  
Results demonstrated that the dispersed phase flux does not have a significant influence on 
particle size and span in the range from 1.15 to 12.84 Lh
-1
m
-2
. An average diameter (D[3,2]) and a 
span of distribution equal to 1.10 µm and 0.50 were obtained, respectively. This flux range is 
identified as “dripping” regime 
31,34
. The droplets are rapidly detached from the membrane surface 
and the contribution of the inertial force from the dispersed phase to the droplet sizes was 
negligible respect to the viscous drag and capillary forces. SEM images of the particles produced in 
this range are reported in Figure 2 (C1). The images reveal the homogenous size distributions and 
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 spherical shapes. An approximately linear increase in the particle size and span was observed 
when the dispersed phase flux was further increased in the range from 12.84 to 30.67 Lh
-1
m
-2
. A 
similar trend was previously reported in the literature for the production of other polymeric 
particles and emulsions.
33,34,36
 The formation of larger droplets was the result of the faster increase 
in the droplet growth as the dispersed phase flux was increased. At 18.02 L h
-1
m
-2
 droplets were 
sheared off from the membrane surface before coalescence at the pore level. Uniform droplets 
(span = 0.8) were then produced although a slight increase in the droplet sizes was obtained 
(D[3,2]= 1.65 µm) (Figure 2, C2). The further increase of the dispersed phase flux generated less 
uniform (span = 1.6) and larger particles (D[3,2]= 3.6 µm) (Figure 2, C3).  
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Figure 2. Effect of maximum shear stress and dispersed phase flux on particle size and particle size 
distribution at lower. A) Modification of dispersed phase flux at maximum shear stress of 2.48 Pa. 
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 B) Modification maximum shear stress at dispersed phase flux of 2.5 Lh
-1
m
-2
. C1, C2, C3 SEM 
images of the particles represented in the graph 
 
Results demonstrate that PLGA-PEG particles with sufficiently narrow distribution in the droplet 
size (span lower than 0.55) and mean diameter tending to the membrane pore diameter can be 
produced for dispersed phase fluxes in the range of 1.15 to 12.84 Lh
-1
m
-2
. The increase in the 
dispersed phase flow determines an increase in the throughput from 36.18 mg h
-1
 to 402 mg h
-1
 
reducing the operation time from 1.38 to 0.12 h. Data indicate that membrane emulsification can 
satisfy the demand of advanced manufacturing processes for industrial scale production by 
connecting efficiency and productivity. With their easy scale-up and large operational flexibility, 
membrane operations have been developed to the stage of large scale manufacture 
29
 and 
membrane emulsification has also demonstrated its capability for large scale industrial operations 
37
.  
 
Effect of maximum shear stress  
In pulsed back-and-forward ME, the shear stress is a function of the frequency and the amplitude 
of the pulsation along the lumen side of the membrane. The amplitude of the pulsation was kept 
constant (47.1 mm) while the increase of the continuous phase flow rate in the range from 500 to 
1200 mL min
-1
 determined an increase in the frequency from 1.49 to 3.57 Hz. Figure 2B shows the 
effect of the maximum wall shear stress on PLGA-PEG particle size and particle-size distribution. 
Particle size (mean droplet diameter = 1.25 ± 0.13 µm) was not significantly influenced as the 
shear stress was increased in the range of values investigated (from 1.12 to 4.16 Pa). Typically, the 
mean particle decreases sharply as the wall shear stress increases and reaches a size where it 
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 becomes more or less independent of the shear. This effect is decreased in case of the production 
of submicron droplets and relatively small droplets are produced at lower shear stress.  
The development of environmentally benign methods for manufacturing processes has become 
increasingly relevant in the last years determining a significant expansion in the development of 
more energy-efficient methodologies. Unutilized energy may be considered as a waste and the 
design of manufacturing processes that do not require intensive energy use is highly desirable. 
Membrane emulsification is a valuable technology to asses this goal. In the present work, the 
energy consumption used during the membrane emulsification process was reduced in the range 
from 9.50 10
5
 to 3.90 10
5
 Jm
-3
 as the maximum shear stress was decreased from 4.16 and 1.12 Pa. 
Considering that a shear stress of 1.12 Pa was enough to produce uniform particles (span = 0.6) 
with D[3,2] of 1.17 µm (tending to the membrane pore size), the further increase of the shear 
stress was not needed minimizing also energy consumption. Furthermore, traditional 
emulsification techniques are known to be rather energy consuming
38,39
. The energy consumption 
associated with the use of an homogenizer, a sonicator and a magnetic stirrer is 10
6
-10
8
 Jm
-3
 
40
 
that is 1-3 orders of magnitude higher that the value measured in the present work.  
Results clearly indicate that membrane emulsification allows operating under mild conditions to 
generate uniform droplets with mean diameters tending to the pore diameter reducing, at the 
same time, energy consumption.  
 
Effect of process conditions used in the solidification step  
In the production of PLGA-PEG microparticles by membrane emulsification- solvent diffusion 
method, both the organic solvent phase, in which the polymer is dissolved, and the aqueous 
continuous phase saturated with the organic solvent, are in the state of thermodynamic 
equilibrium. The addition of a certain volume of continuous phase to the system destabilizes the 
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 equilibrium. It causes the organic solvent to diffuse to the external phase and precipitates the 
polymer to form the solidified particles. Solvent removal determines droplet volume reduction by 
a shrinkage factor given by the chemical composition of the organic phase and defined as the ratio 
between the liquid droplet diameter and the solidified particle diameter 
41
 .  
The effect of the type of organic phase solvents (EA or DCM) and solidification diffusion velocity on 
PLGA-PEG mean particle size, size distribution and particle morphology were investigated. On the 
other hand, for drug encapsulation, it is required that all the chemicals are used (such as solvents, 
polymer, and reagents) reducing or eliminating the generation of undesirable products that could 
be harmful both for human health and the environment. For that reason, sEF and cEF were 
evaluated for each chemical used in the production of PLGA-PEG microparticles. 
 
Effect of organic solvent phase 
Variations in particle size and particle morphology were observed when different organic solvents 
were used in the preparation of PLGA-PEG microparticles by the membrane emulsification/solvent 
diffusion method. Figure 3A reports the average diameter and span of PLGA-PEG particles 
produced by using EA or DCM as polymer solvent while SEM images of PLGA-PEG particles are 
reported in Figure 3C. More heterogeneous particles (span = 0.95) with an average diameter of 
three times the pore size of the membrane (D[3,2] =3.15 µm) were obtained when DCM was used. 
SEM images confirmed the heterogeneous distribution of the particles and revealed the presence 
of large holes and protuberances on the particles (Figure 3C1). On the contrary, uniform particles 
(span = 0.62) with an average diameter close to the pore size of the membrane (D[3,2] =1.25 µm) 
were produced by using EA. SEM images show a dense and slightly rough surface without pores 
(Figure 3 C2). The differences observed in terms of particle-size distribution and morphology are 
strictly correlated with the solvent solubility in the water phase. The miscibility of the solvent in 
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 water influences the diffusion velocity and has a direct impact on the final size of the particles 
20
. 
EA has a water miscibility (SEA=9.7 wt%) 4.5 times higher than DCM and, as a result, EA-Water 
interfacial tension (6.8 ±0.6mN m
-1
) is significant lower than DCM-Water interfacial tension (28.28 
± 0.40 m Nm
-1
) 
42,43
. In addition, since PLGA-PEG microparticles are formed from the emulsion 
droplets after organic solvent diffusion, emulsion droplets stability plays an important role to tune 
the properties of the structured particles. Uniform and smaller particles produced by using EA 
resulted from both the ability of the emulsifier (Pluronic P127) to prevent droplet coalescence, 
and the low interfacial tension between the aqueous and the organic phases, due to the partially 
water-soluble nature of EA. On the contrary, the boiling point of DCM is lower than the one of EA, 
allowing a flash solvent evaporation. Its miscibility with water is also lower, delaying solvent 
diffusion and increasing the solidification time. This determines the formation of pores and holes 
(Figure 3C1) as well as droplet aggregation probably responsible for the production of larger mean 
particle sizes. Similar results were found by Song et al. using PLGA as polymer, EA and DCM as 
solvents and Dimethylamine borane (DMAB) as surfactant 
20
. 
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Figure 3. The effect of organic solvent type on A) particle size, particle-size distribution of particles. 
B) EE and DL  (membrane emulsification/ solvent diffusion) and on particles morphology. C) 
(Polymer: PLGA-PEG, Surfactant: Pluronic, Vd/Vth= 3, PTM/Pc= 1.20, Shear stress: 2.48Pa ). C1) 
SEM image of the particles PLGA-PEG particles produced with DCM. C2) SEM image of the particles 
PLGA-PEG particles produced with EA. 
 
EE and DL were also evaluated (Figure 3B). The use of EA improves the encapsulation efficiency up 
to 50% respect to the use of DCM. The analysis of the particle morphology previously discussed 
can suggest that the porous surface of PLGA-PEG particles produced with DCM determined the 
enhanced leakage of the dexamethasone into the continuous phase. Similar results were 
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 previously reported by Imbrogno et al. for porous particles produced by using Polycaprolactone as 
polymer and DCM as solvent 
44
. The use of EA also improved DL up to 50% reducing the content of 
the carrier material 
45
 minimizing waste generation and improving production profitability. For 
that reason, sEF and cEF values and particle costs were evaluated in this section (Table 1).  
The generation of any material that does not have realizable value, such as the non-encapsulated 
drug, can be considered as a waste. The non-encapsulated drug may affect the environment 
differently depending on its nature, toxicity or dose. On the other hand, maximizing the use of raw 
materials (such as drugs and carrier materials) so that the final formulation contains the maximum 
number of atoms coming from the reactants is the key point to design an efficient and sustainable 
manufacturing process.  
sEF and cEF values were calculated when EA or DCM were used as organic solvents (Table 1). The 
evaluation of sEF and cEF plays a major role when focusing the attention on the problem of waste 
generation in pharmaceutical particle manufacturing and provides the impetus for developing 
cleaner and more sustainable processes. sEF and cEF values were reduced by 80%, when EA was 
used compared to DCM.  
 
Table 1. The effect of organic solvent type and solidification velocity on green metric factors in 
memrane emulsification/solvent diffusion  
 Solvent DCM EA EA EA EA 
 Vd/Vth 3 3 1 0.5 0 
Green 
Analysis 
sEF (mg/mg) 290.99 59.18 23.66 14.78 5.90 
cEF 25503.38 5237.41 2140.03 1365.69 591.35 
% cEF litd 1.14% 1.13% 1.11% 1.08% 1.00% 
% solvent + water 98.86% 98.85% 98.85% 98.85% 98.84% 
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 Economic 
Analysis 
Polymer Price 
(Euros/g product) 
50.00 
Drug Price(Euros/g 
product) 
34.50 
Surfactant Price 
(Euros/g product) 
581.78 118.15 47.12 29.36 11.60 
Solvent Price 
(Euros/g product) 
0.57 0.54 
Water Price (Euros/g 
product) 
25.07 5.04 1.98 1.22 0.45 
Total (Euros/g 
product) 
691.92 208.23 134.14 115.61 97.09 
 
Table 1 summarizes the economic analysis and the breakdown of the chemical reagents involved 
in the production of Dexamethasone loaded PLGA-PEG particles. Particle cost was reduced by 70%, 
when EA was used compared to DCM using Vd/Vth =3 (Table 1) as a result of the low amount of 
water and emulsifier required to obtain particle solidification when using EA. When particle 
solidification occurs by solvent diffusion, solvent solubility strictly influences the amount of non-
solvent (i.e., water) and surfactant required for solvent-non-solvent exchange 
7
. EA is more soluble 
in water than DCM and the amount of water and surfactant required for droplet solidification is 
lower (Table I). This difference is the main reason to explain why costs were reduced for PLGA-PEG 
particles produced at the same Vd/Vth ratio with EA (208.23 Euros/g product) and DCM (691.92 
Euros/g product ). In addition, EA results to be a greener solvent for the production of drug 
delivery systems based on PLGA-PEG considering both its E factor and its low toxicity. Several 
researchers have analyzed the toxicity on human cell lines of PLGA-PEG particles produced using 
EA as a solvent, observing that particles do not alter cell proliferation. This indicates that the PLGA 
delivery systems prepared by using EA are nontoxic at the doses used 
46–48
. 
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Solidification diffusion velocity 
The influence of Vd/Vth ratio on PLGA-PEG particle size and span is presented in Figure 4. The 
solidification rate of the emulsion droplets is directly related to the solvent diffusion volume. 
Results indicate that particle sizes were almost independent on Vd/Vth ratio. Uniform particles 
(span <0.60 ) with an average diameter of 1.25 µm were produced (Figure 4A, 4C). EA has a low 
vapour pressure that makes its evaporation very fast (EA Vapor Pressure: 0.13 bar at 25
o
C). This 
promotes the solidification process because the emulsification-diffusion method guarantees the 
free solvent diffusion as long as the organic solvent solubility condition is satisfied 
49
. Considering 
the partially water-soluble nature of EA, its fast diffusion from the droplets was expected.  
DEX EE was decreased from 61.22 (±3.00)% to 57.12(±3.56)% when the Vth/Vo was increased from 
0 to 3 (Figure 4B) as a result of the increase in the concentration gradient of the encapsulated DEX 
toward the external aqueous phase during the solidification process 
25
.  
Green metric factors were calculated and are presented in Table 1. sEF and cEF values were 
reduced by 90.03%, when Vd/Vth =0 (no diffusion solution added) was used compared to Vd/Vth =3. 
Data indicate that the use of EA allowed reducing the water consumption and the surfactant 
amount used in the solidification step. This determines also a cost reduction of 53.38% as a 
function of Vd/Vth (from 3 to 0). (Table 1).  
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Figure 4. The effect of solidification velocity on A) particle size, particle-size distribution of 
particles, B) EE and DL (membrane emulsification/ solvent diffusion) and on particles morphology 
C) (Polymer: PLGA-PEG, Surfactant: Pluronic, Organic solvent: EA, PTM/Pc= 1.2, Shear stress: 
2.48Pa ). C1) SEM image of the particles PLGA-PEG particles produced with Vt/Vo =0. C2) SEM 
image of the particles PLGA-PEG particles produced with Vt/Vo =3. 
In the present work, the production of PLGA-PEG particles as potential drug delivery vectors was 
assessed by using membrane emulsification/solvent diffusion method. The optimized operative 
conditions during the emulsification (DP flux = 12.84 Lh
-1
m
-2
, shear stress = 1.12 Pa) and the 
solidification steps (solvent= EA, Vd/Vth = 0) allowed to produce uniform particles (span = 0.62) 
with an average particle size of 1.25 µm and an EE of 61.22%. High throughput was achieved by 
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 increasing the dispersed phase flux to 12.84 Lh
-1
m
-2
 in mild operative conditions (shear stress = 
1.12 Pa) reducing at the same time the energy consumption (3.96.10
5
 Jm
-3
). EA resulted to be a 
valuable alternative solvent for PLGA particle production as being a greener solvent considering 
both green metric factors and toxicity compared to the use of DCM. The use of EA makes the 
particle production process more sustainable reducing the volume of water consumed and the 
amount of emulsifier used. This allowed also decreasing the economic impact of these 
components. 
 
A comparison with the literature  
Recent works on the production of PLGA-PEG particles by emulsification-solvent diffusion method 
is analysed in this section with the aim to demonstrate the sustainability of the manufacturing 
method used in the present work. The use of membrane-emulsification in the preparation of PLGA 
particles has been previously reported 
50–53
 however; the greenness of this process has not been 
measured.  
Energy density and process throughput obtained in the present work are compared with data 
calculated from previous works in which membrane-based processes 
50,53
 and also conventional 
emulsification methods 
7,9,49
 have been used during PLGA particle production (Table 2). 
Considering the similar physicochemical properties of PLGA and PLGA-PEG polymers 
49
, literature 
data about PLGA particles manufacturing were used for the comparison according to the 
availability of all the information required for throughput and energy density calculations (see 
supplementary materials section).  
One of the frequently mentioned advantages of membrane emulsification over conventional 
emulsification methods is the lower energy density requirement
54
. The concept of energy density 
has been previously applied to compare different mechanical emulsifying processes
54,55
. The 
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 comparison illustrates that, given equal energy densities, different emulsifying equipment (rotor-
stator systems, ultrasound systems, high-pressure homogenizers and membrane emulsifiers) 
produces very different droplet sizes. In membrane emulsification, particles with a mean diameter 
approximately equal to were produced with an energy density in the range of 10
3
-10
6
 Jm
-3
 which is 
1-2 orders of magnitude smaller than in high-pressure valve homogenizers
54
. In the present work, 
we compared the energy density required for the production of PLGA particles by using different 
mechanical emulsifying processes. The comparison illustrates that only the pulsed back-and-
forward method allowed decreasing effectively the energy density respect to the other 
conventional emulsification methods. It is well known that higher energy densities are needed to 
produce smaller droplets
54,55
. For that reason, results obtained in the present work by using the 
pulsed back-and-forward method are more relevant if we consider that the mean particle size 
(1.25 µm) is significantly smaller that the size reported by other membrane emulsification 
methods (60-120 µm) 
50
 or by conventional emulsification methods (15-80 µm) 
15,56,57
. Slightly 
smaller particles (mean particle size = 0.4-0.6 µm) with high throughput (3 10
-7
 m
3
s
-1
) were 
produced by using the sonicator in the emulsification step but with a significant increase in the 
energy consumption (from 10
5
 Jm
-3
 by using pulsed-back-and-forward membrane emulsification to 
10
8
 Jm
-3 
by using a sonicator). 
40
 Pulsed back-and-forward membrane emulsification appears to be 
an alternate valuable method with low energy consumption (3 orders of magnitude lower) respect 
to other membrane emulsification methods of operation for the production of particles in the 
same range of sizes
53
 although the process throughput was one order of magnitude lower than 
those associated with the conventional emulsification methods. 
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Table 2. Comparison between the membrane emulsification/solvent diffusion process and processes described in the literature  
  MEMBRANE EMULSIFICATION CONVENTIONAL EMULSIFICATION METHOD 
  Present Work 
Ho et al, 
2013 
53
 
Gasparini et 
al, 2008 
50
 
Kim and 
Martin, 2006 
58 
Gu and Burgess, 
2015 
15 
Park et al, 
2009 
56 
Goodfriend et al, 
2016 
57 
Chemical 
Composition 
Polymer PLGA-PEG PLGA PLGA PLGA PLGA PLGA PLGA 
Drug DEX curcumin N/A DEX DEX DEX DEX 
Solvent EA Chloroform DCM DCM/Acetone DCM DCM Tetrahydrofuran 
Surfactant  Pluronic F127 PVA PVA PVA PVA PVA Pluronic F127 
Dispersed Phase/Continuous 
Phase ratio 
0.20 0.10 0.07 0.20 0.20 0.10 1.00 
Total Volume (mL) 30.00 6.60 160.00 180.00 137.00 330.00 10.00 
Emulsification 
Process 
Membrane 
SPG 
Membrane 
Dp= 1um 
Silicon 
nitride 
membrane 
Dp= 2um 
Metallic 
membrane  
Dp= 40um 
- - - - 
Emulsification Device 
Cross-Flow 
pulsed back-
and-forward 
Cross-Flow Stirred  
Sonicator 
(Fisher 500) 
T 25 digital 
ULTRA-TURRAX 
homogenizer 
Magnetic 
stirrer 
Vortexed stirrer 
Throughput (m3 s-1) 1.32*10
-08
 2.20*10
-08
 1.33*10
-07
 3.00*10
-07
 2.00*10
-07
 5.50*10
-07
 5.56*10
-09
 
Formulation 
Properties 
Mean Particle size (um) 1.25 2.30 
60.00 
 
0.40–0.60 15.00 20.00 50.00 
EE % 61.20 32.00 N/A 79.00±5.00 70-95 N/A 60.00 
DL % 6.16 2.00 N/A 13.00±3.00 10 N/A N/A 
Energy 
Consumption 
Energy density (Jm-3) 3.96*10
-05
 2.29*10
-08
 2.25*10
-08
 2.00*10
-08
 1.60*10
-09
 1.09*10
-08
 2.52*10
-08
 
Green Analysis 
sEF 5.90    0.71   
cEF 591.35    313.17   
% cEF litd 1.00%    0.23%   
% solvent + water 98.84%    99.45%   
Economic 
Analysis 
Polymer Price (Euros/g 
product) 
50.00 50.00 50.00 50.00 50.00 50.00 50.00 
Drug Price(Euros/g product) 34.50 34.50 N/A 86.25 70.38 3.45 215.63 
Total Cost (Euros/g product) 97.09 106.09 52.14 155.35 121.73 56.56 265.68 
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Green metric factors obtained for the method developed in the present work were compared with 
the same data calculated for the method described by Gu and Burgess 
15
. This paper was the only 
one that included data referred to both emulsification and solvent diffusion steps, while other 
papers analysed in this section only referred to the emulsification step 
50,53,56–58
 sEF and cEF 
resulted to be quite similar and the most important difference was attributed to the amount of 
polymer and drug used. The ratio between sEF and cEF values (% cEF litd) is a helpful indicator for 
relative solvent usage and thus waste reduction potential. The low % cEF litd value (lower than 1%) 
and the relative value of solvent and water percentages higher than 95% indicated that, solvents 
(organic solvent and water) are the most utilized material in the production of polymer particles 
via emulsification and solvent diffusion.  
Similar analysis previously conducted in the pharmaceutical field confirms the higher contribution 
of solvents to the cumulative PMI. The relative value of solvent and water percentages associated 
with the production of active ingredients from a survey of several pharmaceutical companies was 
estimated to be 88% by the Pharmaceutical Roundtable
57
. In contrast, the results for the 
commercial route show a lower relative value of solvent and water percentage solvent of 78%
58
. 
Anyway, the environmental impact of the solvent depends on the environmental factor and the 
solvent type as previously discussed.   
Solvents used for the production of PLGA particles included in Table 2 are DCM 
50,56,58
 and 
chloroform 
53
. Both, Chloroform and DCM have been classified as Class 2 with a permissible 
concentration of 60 ppm for Chloroform and (lower than that allowed for DCM) 
59
. EA is classified 
as a Class 3 solvent and then it results a greener solvent respect to the solvents previously used in 
PLGA particles production. EQ-factor (environmental quotient factor) was proposed as a valuable 
extension of E-factor in order to consider the toxicity of materials and it is obtained by multiplying 
the E factor with an arbitrarily assigned unfriendliness quotient, Q. However, the magnitude of Q is 
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currently debatable and difficult to quantify and this hampers the correct assessment of a green 
analysis. 
60
 Several general purpose solvents, 
22
 analyzing the most conventional solvents taking 
into account the European regulation concerning the ‘Registration, Evaluation, Authorisation and 
Restriction of Chemicals’ (REACH) and the recommendations of pharmaceutical industry solvent 
selection guides identified EA as recommended/preferred solvent while Chloroform and DCM as 
undesirable. 
The economic analysis performed demonstrates that the cost of the microparticles was 
97.09euro/g of particles produced. It is important to point out that in the calculation only the raw 
material costs are included, however, the calculation helps to identify the components influencing 
most significantly the cost of particle production. Main cost components result to be the polymer 
(51.15%) and the drug (35.45%) as reported also in previous works 
15,50,53,56–58
.  
About the formulation properties, it is notable that EE and DL for DEX encapsulation previously 
reported in Table 2 were close to those obtained in the present work. This indicates that the 
encapsulation efficiency is not correlated with the emulsification method used. EE and DL are 
highly dependent on the polymer and drug initial amounts, surfactant type, concentration and 
solvent type
15,49
. A low initial amount of drug used in the present work (1 mg L
-1
) is responsible for 
a lower EE obtained respect to other data reported in Table 2 (EE = 70%, initial drug concentration 
= 6.66 mg L
-1 58
 and 44.93 mg L
-1 15
).  
The simplicity and versatility of the membrane emulsification method combined with the use of 
green solvents hold much promise for the development of a sustainable chemical manufacturing 
industry. Considering that a broad spectrum of micro-nanostructured materials with predictable 
and controllable sizes, different chemical compositions, morphologies, and functionalities can be 
produced by using the proposed method, membrane-based technologies result the best green 
process choice.  
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Associated content  
Full details about the intensification analysis (mass balance, economic, green analysis and energy 
consumption) of the described process are provided in the Supplementary Information. 
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